insights_auto
Why is IOVA down 5.42%?
Dive Deeperchevron_right
IOVA:NASDAQ
Iovance Biotherapeutics Inc
$8.02
arrow_downward
-5.42%(-0.46) 1D
$7.98
arrow_downward
-0.54% (-0.044)bedtimeAfter hours
Closed: Nov 2, 4:00:01 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for IOVA...
Open
$8.52
High
$8.56
Low
$7.66
Mkt. cap
3.63B
Avg. vol.
17.13M
Volume
21.05M
52-wk high
$15.37
52-wk low
$1.76
EPS
-$0.72
Beta
0.76
Shares outstanding
452.97M
No. of employees
975
Open
$8.52
High
$8.56
Low
$7.66
Mkt. cap
3.63B
Avg. vol.
17.13M
Volume
21.05M
52-wk high
$15.37
52-wk low
$1.76
EPS
-$0.72
Beta
0.76
Shares outstanding
452.97M
No. of employees
975
News stories
From web sources and news partners
Zacks
·
11 hours ago
Iovance Gears Up to Report Q3 Earnings: Here's What to Expect
Zacks
·
11 hours ago
ETON Gears Up to Report Q3 Earnings: What Can Investors Expect?
Profile
Iovance Biotherapeutics, Inc. is a biopharmaceutical company based in Philadelphia, Pennsylvania. The company works to develop tumor-infiltrating lymphocyte therapies against cancer. Wikipedia
About Iovance Biotherapeutics Inc
CEO-
Employees975
Founded2007
HeadquartersSan Carlos, California, United States
SectorBiotechnology
Websiteiovance.com